DUX4
Assets acting on this target.
- Class
- DUX4-targeted siRNA (RNAi)
By indication
DUX4 drugs compared
2 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| Delpacibart braxlosiran | Novartis | antibody-oligonucleotide conjugate (siRNA) | Phase 3 | Phase 3 in Facioscapulohumeral Muscular Dystrophy |
| SRP-1001 | Arrowhead Pharmaceuticals, Sarepta Therapeutics | RNAi (siRNA) | Phase 1/2 | Phase 1/2 in Facioscapulohumeral Muscular Dystrophy |